Tenaya Therapeutics Launches with the Goal of Curing Heart Disease
Tenaya Therapeutics Launches with the Goal of Curing Heart Disease
A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure.
Institutional News News Release Heart Failure